SkinBioTherapeutics PLC (LSE: SBTX) is a life sciences company focused on skin health and microbiome-based therapies. Its lead product, AxisBiotix-Ps™, targets psoriasis via gut-skin axis modulation, delivered through a food supplement. The company also explores applications in wound healing, cosmetics, and oral care. With consumer health shifting towards preventative and natural products, SkinBioTherapeutics is building commercial traction in a novel sector.